Literature DB >> 25433736

Intraocular pressure variations: causes and clinical significance.

Arthur J Sit1.   

Abstract

Reduction of intraocular pressure (IOP) is the only known effective treatment for glaucoma. However, IOP is a highly variable and dynamic parameter, undergoing virtually constant changes from numerous factors, including body position and circadian rhythms. Despite this variability, evidence for the efficacy of IOP reduction in glaucoma is based on studies designed to assess mean IOP and not IOP variations. Post hoc analysis of data from major clinical trials has suggested that IOP variations may be an independent risk factor for the development of glaucoma or glaucomatous progression, at least in some patients, but the evidence is incomplete and further studies are required. In the interim, judicious selection of existing therapies can help to minimize IOP variations. In general, therapies that improve outflow instead of suppressing aqueous humor production result in more stable IOP. However, new technology to allow better monitoring of IOP, ideally in a continuous 24-hour manner, is required to fully understand the role of IOP variations in glaucoma.
Copyright © 2014 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25433736     DOI: 10.1016/j.jcjo.2014.07.008

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  14 in total

Review 1.  [Assessment of risk factors for the occurrence of open angle glaucoma : Guidelines of the German Ophthalmological Society and the Professional Association of Ophthalmologists in Germany].

Authors: 
Journal:  Ophthalmologe       Date:  2021-01       Impact factor: 1.059

Review 2.  Neuro-protection and neuro-regeneration of the optic nerve: recent advances and future directions.

Authors:  Kimberly K Gokoffski; Micalla Peng; Basheer Alas; Phillip Lam
Journal:  Curr Opin Neurol       Date:  2020-02       Impact factor: 5.710

3.  Measurement of Intraocular Pressure by Patients With Glaucoma.

Authors:  Savva Pronin; Lyndsay Brown; Roly Megaw; Andrew J Tatham
Journal:  JAMA Ophthalmol       Date:  2017-10-01       Impact factor: 7.389

4.  Tau Accumulation, Altered Phosphorylation, and Missorting Promote Neurodegeneration in Glaucoma.

Authors:  Marius Chiasseu; Jorge L Cueva Vargas; Laurie Destroismaisons; Christine Vande Velde; Nicole Leclerc; Adriana Di Polo
Journal:  J Neurosci       Date:  2016-05-25       Impact factor: 6.167

Review 5.  Retinal Ganglion Cell Replacement: Current Status and Challenges Ahead.

Authors:  Adam M Miltner; Anna La Torre
Journal:  Dev Dyn       Date:  2018-10-11       Impact factor: 3.780

Review 6.  Cell transplantation to replace retinal ganglion cells faces challenges - the Switchboard Dilemma.

Authors:  Yuan Liu; Richard K Lee
Journal:  Neural Regen Res       Date:  2021-06       Impact factor: 5.135

7.  The association between retinal thickness variations and restless leg syndrome (RLS).

Authors:  Lorenzo Ferro Desideri; Fabio Barra; Simone Ferrero
Journal:  Sleep Breath       Date:  2019-03-18       Impact factor: 2.655

8.  Genetic correlations between intraocular pressure, blood pressure and primary open-angle glaucoma: a multi-cohort analysis.

Authors:  Hugues Aschard; Jae H Kang; Adriana I Iglesias; Pirro Hysi; Jessica N Cooke Bailey; Anthony P Khawaja; R Rand Allingham; Allison Ashley-Koch; Richard K Lee; Sayoko E Moroi; Murray H Brilliant; Gadi Wollstein; Joel S Schuman; John H Fingert; Donald L Budenz; Tony Realini; Terry Gaasterland; William K Scott; Kuldev Singh; Arthur J Sit; Robert P Igo; Yeunjoo E Song; Lisa Hark; Robert Ritch; Douglas J Rhee; Vikas Gulati; Shane Haven; Douglas Vollrath; Donald J Zack; Felipe Medeiros; Robert N Weinreb; Ching-Yu Cheng; Daniel I Chasman; William G Christen; Margaret A Pericak-Vance; Yutao Liu; Peter Kraft; Julia E Richards; Bernard A Rosner; Michael A Hauser; Caroline C W Klaver; Cornelia M vanDuijn; Jonathan Haines; Janey L Wiggs; Louis R Pasquale
Journal:  Eur J Hum Genet       Date:  2017-08-30       Impact factor: 5.351

9.  Comparison of Ocular Pulse Amplitude Lowering Effects of Preservative-Free Tafluprost and Preservative-Free Dorzolamide-Timolol Fixed Combination Eyedrops.

Authors:  Du Ri Seo; Seung Joo Ha
Journal:  Biomed Res Int       Date:  2015-10-18       Impact factor: 3.411

Review 10.  Glaucoma history and risk factors.

Authors:  Charles W McMonnies
Journal:  J Optom       Date:  2016-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.